Mini Review
Published on 22 Aug 2016
Biomarkers in DILI: One More Step Forward
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00267
- 12,731 views
- 57 citations
Type at least 3 characters
551 articles
Articles
Original Research
Published on 08 Aug 2016
Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00241
- 6,335 views
- 34 citations
Original Research
Published on 05 Aug 2016
Genetic Polymorphisms Associated to Folate Transport as Predictors of Increased Risk for Acute Lymphoblastic Leukemia in Mexican Children
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00238
- 4,822 views
- 6 citations
Perspective
Published on 04 Aug 2016
Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00237
- 9,121 views
- 38 citations
Original Research
Published on 20 Jul 2016
Asthma and Rhinitis Induced by Selective Immediate Reactions to Paracetamol and Non-steroidal Anti-inflammatory Drugs in Aspirin Tolerant Subjects
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00215
- 7,870 views
- 18 citations
Original Research
Published on 18 Jul 2016
HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00186
- 16,880 views
- 63 citations
Review
Published on 12 Jul 2016
In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00204
- 8,923 views
- 28 citations
Mini Review
Published on 17 Jun 2016
Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions—Potential and Limitations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00171
- 9,258 views
- 26 citations
Original Research
Published on 14 Jun 2016
Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00135
- 7,115 views
- 35 citations
Mini Review
Published on 14 Jun 2016
MinION: A Novel Tool for Predicting Drug Hypersensitivity?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00156
- 6,353 views
- 7 citations
Original Research
Published on 25 Apr 2016
Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00098
- 4,375 views
- 9 citations
Original Research
Published on 31 Mar 2016
Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of Cholestasis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00085
- 6,628 views
- 31 citations
Original Research
Published on 28 Jan 2016
MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00324
- 6,635 views
- 22 citations
Original Research
Published on 26 Jan 2016
Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX® ADME PGx Panel for Pharmacogenomic Profiling
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00001
- 6,920 views
- 43 citations
Original Research
Published on 12 Jan 2016
CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6*15 and *35 Genotyping
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00312
- 6,538 views
- 16 citations
Original Research
Published on 04 Nov 2015
Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2015.00261
- 6,992 views
- 19 citations